| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,597 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,596 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,071 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,375 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,033 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
608 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7268110 |
Agents for preventing and treating thrombocytopenia |
Sep. 11, 2007 |
| 7268109 |
Method for reducing pain |
Sep. 11, 2007 |
| 7268108 |
Alpha-melanocyte stimulating hormone derivatives and cosmetic application thereof |
Sep. 11, 2007 |
| 7267822 |
Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
Sep. 11, 2007 |
| 7267820 |
Neurotransmission disorders |
Sep. 11, 2007 |
| 7265157 |
Sustained release compositions, process for producing the same and use thereof |
Sep. 4, 2007 |
| 7265089 |
KGF polypeptide compositions |
Sep. 4, 2007 |
| 7265083 |
Treatment of idiopathic pulmonary fibrosis using IP-10 |
Sep. 4, 2007 |
| 7264819 |
Lyase treatment for P. carinii |
Sep. 4, 2007 |
| 7264799 |
Use of heparinases to decrease inflammatory response |
Sep. 4, 2007 |
| 7264793 |
Numb protein expression inhibitors by Musashi |
Sep. 4, 2007 |
| 7262177 |
Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use |
Aug. 28, 2007 |
| 7262170 |
Pharmaceutical composition for reducing vaginal acidity and treatment of vaginitis, and the use thereof |
Aug. 28, 2007 |
| 7262166 |
Chemically modified novel erythropoietin stimulating protein compositions and methods |
Aug. 28, 2007 |
| 7262164 |
Polymeric thiol-linked prodrugs employing benzyl elimination systems |
Aug. 28, 2007 |
| 7262163 |
Short amphipathic peptides with activity against bacteria and intracellular pathogens |
Aug. 28, 2007 |
| 7262162 |
Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system |
Aug. 28, 2007 |
| 7261892 |
Methods for diagnosis and treatment of epithelial-derived cancers |
Aug. 28, 2007 |
| 7261882 |
Methods for treating neuropathic pain by administering IL-10 polypeptides |
Aug. 28, 2007 |
| RE39789 |
Tumor therapy |
Aug. 21, 2007 |
| 7259143 |
Method of extending the dose range of vitamin D compounds |
Aug. 21, 2007 |
| 7259138 |
Anti-tumor agents |
Aug. 21, 2007 |
| 7259137 |
Peptides and related molecules that bind to TALL-1 |
Aug. 21, 2007 |
| 7259136 |
Compositions and methods for treating peripheral vascular disease |
Aug. 21, 2007 |
| 7258999 |
PTH responsive gene |
Aug. 21, 2007 |
| 7258864 |
Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency |
Aug. 21, 2007 |
| 7258861 |
TNF-derived peptides for use in treating oedema |
Aug. 21, 2007 |
| 7258853 |
Antagonists of interleukin-15 |
Aug. 21, 2007 |
| 7256174 |
Somatostatin and somatostatin agonists for treating insulin insensitivity and Syndrome X |
Aug. 14, 2007 |
| 7256172 |
Method of treatment and agents useful for same |
Aug. 14, 2007 |
| 7255872 |
Method for immobilization of mediator molecules on metallic and ceramic implant materials |
Aug. 14, 2007 |
| 7255867 |
Vaccine |
Aug. 14, 2007 |
| 7255866 |
Botulinum toxin therapy for fibromyalgia |
Aug. 14, 2007 |
| 7255865 |
Methods of administering botulinum toxin |
Aug. 14, 2007 |
| 7255863 |
Group A streptococcal vaccines |
Aug. 14, 2007 |
| 7255854 |
Use of lymphotoxin-.beta. receptor blocking agents for the treatment of antibody mediated immunological diseases |
Aug. 14, 2007 |
| 7254487 |
Methods for determining therapeutic index from gene expression profiles |
Aug. 7, 2007 |
| 7253146 |
Template-fixed peptidomimetics with antimicrobial activity |
Aug. 7, 2007 |
| 7253144 |
Method for producing by cell-free protein synthesis system using thioredoxin-fused protein expression vector |
Aug. 7, 2007 |
| 7253143 |
Peptides based on the sequence of human lactoferrin and their use |
Aug. 7, 2007 |
| 7253142 |
Protein solution preparation and method of stabilizing the same |
Aug. 7, 2007 |
| 7252829 |
HLA binding peptides and their uses |
Aug. 7, 2007 |
| 7252827 |
Conserved motif of hepatitis C virus E2/NS1 region |
Aug. 7, 2007 |
| 7250403 |
Biodegradable immunomodulatory formulations and methods for use thereof |
Jul. 31, 2007 |
| 7250397 |
Antiarrhythmic peptides |
Jul. 31, 2007 |
| 7250396 |
Juvenile hormone compositions and methods for making same |
Jul. 31, 2007 |
| 7250395 |
Antagonist peptides to VEGF receptor Flt-1 |
Jul. 31, 2007 |
| 7250394 |
Treatment of glial tumors with glutamate antagonists |
Jul. 31, 2007 |
| 7250273 |
Human peroxisome proliferator activated receptor .gamma.: compositions and methods |
Jul. 31, 2007 |
| 7250262 |
Methods for identifying compounds which modulate hematopoiests |
Jul. 31, 2007 |
|
|
|
